Brief: Xilio Therapeutics Announces First Quarter 2023 Financial Results
09/05/2023 12:57
May 9 (Reuters) - Xilio Therapeutics Inc XLO.O :
* XILIO THERAPEUTICS ANNOUNCES PIPELINE AND BUSINESS UPDATES
AND
FIRST QUARTER 2023 FINANCIAL RESULTS
* XILIO THERAPEUTICS - ENDED Q1 OF 2023 WITH $93.3 MILLION
IN CASH
AND CASH EQUIVALENTS, WITH CASH RUNWAY ANTICIPATED INTO END OF
Q2 OF 2024
* XILIO THERAPEUTICS INC QTRLY NET LOSS PER SHARE, BASIC AND
DILUTED $0.83
Source text for Eikon: ID:nGNX6Czq0H
Further company coverage: XLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla